Connor, Clark & Lunn Investment Management (CC&L)
AEGR

Connor, Clark & Lunn Investment Management (CC&L)’s Aegerion Pharmaceuticals AEGR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AEGR Stock Details AEGR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
2016
Q3 		$316K Hold
2016
Q2 		$159K Buy
2016
Q1 		$269K Sell
2015
Q4 		$783K Buy
2015
Q3 		$964K Buy
2014
Q1 		– Sell
2013
Q4 		$765K Sell
2013
Q3 		$1.11M Sell
2013
Q2 		$972K Buy